207 related articles for article (PubMed ID: 16415042)
1. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy.
Boguslavsky RL; Stewart CL; Worman HJ
Hum Mol Genet; 2006 Feb; 15(4):653-63. PubMed ID: 16415042
[TBL] [Abstract][Full Text] [Related]
2. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
Favreau C; Dubosclard E; Ostlund C; Vigouroux C; Capeau J; Wehnert M; Higuet D; Worman HJ; Courvalin JC; Buendia B
Exp Cell Res; 2003 Jan; 282(1):14-23. PubMed ID: 12490190
[TBL] [Abstract][Full Text] [Related]
3. Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells.
Bechert K; Lagos-Quintana M; Harborth J; Weber K; Osborn M
Exp Cell Res; 2003 May; 286(1):75-86. PubMed ID: 12729796
[TBL] [Abstract][Full Text] [Related]
4. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
[TBL] [Abstract][Full Text] [Related]
5. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.
Favreau C; Higuet D; Courvalin JC; Buendia B
Mol Cell Biol; 2004 Feb; 24(4):1481-92. PubMed ID: 14749366
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation.
Reichart B; Klafke R; Dreger C; Krüger E; Motsch I; Ewald A; Schäfer J; Reichmann H; Müller CR; Dabauvalle MC
BMC Cell Biol; 2004 Mar; 5():12. PubMed ID: 15053843
[TBL] [Abstract][Full Text] [Related]
7. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.
Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G
J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034
[TBL] [Abstract][Full Text] [Related]
8. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
[TBL] [Abstract][Full Text] [Related]
9. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.
Ostlund C; Bonne G; Schwartz K; Worman HJ
J Cell Sci; 2001 Dec; 114(Pt 24):4435-45. PubMed ID: 11792809
[TBL] [Abstract][Full Text] [Related]
10. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
[TBL] [Abstract][Full Text] [Related]
12. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.
Lloyd DJ; Trembath RC; Shackleton S
Hum Mol Genet; 2002 Apr; 11(7):769-77. PubMed ID: 11929849
[TBL] [Abstract][Full Text] [Related]
13. Expression of the myodystrophic R453W mutation of lamin A in C2C12 myoblasts causes promoter-specific and global epigenetic defects.
Håkelien AM; Delbarre E; Gaustad KG; Buendia B; Collas P
Exp Cell Res; 2008 May; 314(8):1869-80. PubMed ID: 18396274
[TBL] [Abstract][Full Text] [Related]
14. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
[TBL] [Abstract][Full Text] [Related]
15. Lamin A/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling.
Perepelina K; Dmitrieva R; Ignatieva E; Borodkina A; Kostareva A; Malashicheva A
Biochem Cell Biol; 2018 Jun; 96(3):342-348. PubMed ID: 29040816
[TBL] [Abstract][Full Text] [Related]
16. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
Holt I; Clements L; Manilal S; Brown SC; Morris GE
Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
[TBL] [Abstract][Full Text] [Related]
17. Structural instability of lamin A tail domain modulates its assembly and higher order function in Emery-Dreifuss muscular dystrophy.
Mio M; Sugiki T; Matsuda C; Mitsuhashi H; Kojima C; Chan SY; Hayashi YK; Mio K
Biochem Biophys Res Commun; 2019 Apr; 512(1):22-28. PubMed ID: 30853177
[TBL] [Abstract][Full Text] [Related]
18. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM
Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751
[TBL] [Abstract][Full Text] [Related]
19. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy.
Wang Y; Herron AJ; Worman HJ
Hum Mol Genet; 2006 Aug; 15(16):2479-89. PubMed ID: 16825283
[TBL] [Abstract][Full Text] [Related]
20. Lamin A/C assembly defects in Emery-Dreifuss muscular dystrophy can be regulated by culture medium composition.
Holt I; Nguyen TM; Wehnert M; Morris GE
Neuromuscul Disord; 2006 Jun; 16(6):368-73. PubMed ID: 16697197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
